Mediwound Financial Statements From 2010 to 2025

Mediwound Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Common Stock Shares Outstanding 10.5 M 10 M 4.6 M Slightly volatile Total Assets 47.4 M 73.5 M 41.2 M Slightly volatile Short and Long Term Debt Total 4.1 M 6.9 M 4.9 M Very volatile Other Current Liabilities 23.1 M 22 M 5.5 M Slightly volatile Total Current Liabilities 27.9 M 26.5 M 9 M Slightly volatile Other Liabilities 15.9 M 23.6 M 18.6 M Slightly volatile Property Plant And Equipment Net 21.8 M 20.8 M 5.5 M Slightly volatile Accounts Payable 3.2 M 4.1 M 2.6 M Slightly volatile Cash 14.6 M 9.2 M 15.8 M Pretty Stable Non Current Assets Total 22.4 M 21.3 M 10 M Very volatile Other Assets 311.2 K 327.6 K 3.2 M Slightly volatile Cash And Short Term Investments 33.1 M 43.2 M 26.5 M Slightly volatile Net Receivables 4.4 M 5.9 M 3.7 M Slightly volatile Common Stock Total Equity 61 K 86.2 K 55.6 K Slightly volatile Liabilities And Stockholders Equity 47.4 M 73.5 M 41.2 M Slightly volatile Non Current Liabilities Total 16.3 M 15.8 M 18.3 M Pretty Stable Inventory 1.8 M 2.7 M 1.5 M Slightly volatile Other Current Assets 551 K 458 K 625.3 K Very volatile Other Stockholder Equity 147.1 M 236 M 123.8 M Slightly volatile Total Liabilities 32.2 M 42.3 M 27 M Slightly volatile Property Plant And Equipment Gross 30.2 M 28.7 M 6.9 M Slightly volatile Total Current Assets 39.5 M 52.2 M 32 M Slightly volatile Short Term Debt 397.1 K 418 K 2.3 M Pretty Stable Intangible Assets 94 K 99 K 1.4 M Slightly volatile Common Stock 225.8 K 215 K 85 K Slightly volatile Property Plant Equipment 2.6 M 4.1 M 2.5 M Slightly volatile Long Term Debt 7.8 M 8.5 M 7.3 M Slightly volatile Deferred Long Term Liabilities 811.4 K 889.2 K 986.1 K Slightly volatile Short and Long Term Debt 2.2 M 2 M 2.4 M Slightly volatile Current Deferred Revenue 11.4 K 12 K 147.6 K Very volatile Non Current Liabilities Other 10.8 M 8.1 M 16.3 M Slightly volatile Capital Surpluse 153.8 M 162 M 142 M Slightly volatile Net Working Capital 21 M 25.6 M 30.2 M Slightly volatile Capital Stock 132.3 K 215 K 98.4 K Slightly volatile Long Term Debt Total 1.6 M 1.8 M 2 M Slightly volatile Capital Lease Obligations 3.5 M 6.5 M 2.5 M Slightly volatile
Mediwound Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 869.2 K 1.5 M 757.9 K Slightly volatile Interest Expense 491.1 K 752 K 604.8 K Slightly volatile Selling General Administrative 5.6 M 9.7 M 4.8 M Slightly volatile Other Operating Expenses 23.9 M 39.6 M 20.8 M Slightly volatile Research Development 6.7 M 8.9 M 6 M Slightly volatile Total Operating Expenses 16.2 M 22 M 14.2 M Slightly volatile Cost Of Revenue 9.1 M 17.6 M 7.6 M Slightly volatile Selling And Marketing Expenses 3.6 M 3.2 M 4 M Pretty Stable Interest Income 2.2 M 2 M 984.1 K Pretty Stable Reconciled Depreciation 1.2 M 1.5 M 860.7 K Slightly volatile
Mediwound Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 2 M 3.1 M 1.7 M Slightly volatile Begin Period Cash Flow 18.4 M 11.9 M 16 M Slightly volatile Depreciation 869.2 K 1.5 M 757.9 K Slightly volatile Capital Expenditures 6.6 M 6.3 M 1.7 M Slightly volatile End Period Cash Flow 8.7 M 9.2 M 15.8 M Very volatile Sale Purchase Of Stock 17.7 M 20.4 M 20.8 M Very volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 8.33 8.7671 190 Slightly volatile Days Sales Outstanding 100 106 1.2 K Slightly volatile Stock Based Compensation To Revenue 0.15 0.1552 6.3146 Slightly volatile Capex To Depreciation 4.44 4.2299 2.0561 Pretty Stable EV To Sales 8.22 8.6571 152 Slightly volatile Inventory Turnover 4.14 6.5334 4.3012 Slightly volatile Days Of Inventory On Hand 53.07 55.8665 150 Slightly volatile Payables Turnover 4.51 4.2939 2.628 Slightly volatile Sales General And Administrative To Revenue 0.46 0.4804 6.5899 Slightly volatile Research And Ddevelopement To Revenue 0.42 0.439 7.7367 Slightly volatile Capex To Revenue 0.4 0.3102 0.6577 Slightly volatile Cash Per Share 8.39 4.3334 6.7386 Very volatile Days Payables Outstanding 80.75 85.0034 198 Pretty Stable Intangibles To Total Assets 0.0013 0.0013 0.0497 Slightly volatile Current Ratio 1.87 1.9654 4.8072 Pretty Stable Receivables Turnover 2.76 3.4556 2.5792 Slightly volatile Capex Per Share 0.66 0.6298 0.2806 Slightly volatile Revenue Per Share 2.3 2.0303 2.149 Slightly volatile Interest Debt Per Share 0.81 0.7714 0.5029 Very volatile Debt To Assets 0.0507 0.0943 0.0571 Pretty Stable Graham Number 17.57 12.18 13.1417 Slightly volatile Operating Cycle 153 161 1.3 K Slightly volatile Days Of Payables Outstanding 80.75 85.0034 198 Pretty Stable Quick Ratio 1.77 1.8639 4.5965 Pretty Stable Net Income Per E B T 1.3 1.002 1.2049 Pretty Stable Cash Ratio 0.33 0.3449 2.5164 Pretty Stable Days Of Inventory Outstanding 53.07 55.8665 150 Slightly volatile Days Of Sales Outstanding 100 106 1.2 K Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.9 1.4604 1.1258 Very volatile Fixed Asset Turnover 0.92 0.9724 2.1357 Slightly volatile Debt Ratio 0.0507 0.0943 0.0571 Pretty Stable Price Sales Ratio 8.33 8.7671 190 Slightly volatile Asset Turnover 0.29 0.2751 0.2681 Slightly volatile
Mediwound Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 80.1 M 90.1 M 98.2 M Slightly volatile Enterprise Value 57 M 64.1 M 69.9 M Slightly volatile

Mediwound Fundamental Market Drivers

Mediwound Upcoming Events

About Mediwound Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:

How To Invest In Mediwound Details

Is Mediwound Stock a good investment? Details

What is Mediwound's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details